SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-017410
Filing Date
2020-08-11
Accepted
2020-08-11 08:00:31
Documents
46
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q snbp20200630_10q.htm 10-Q 561070
2 EXHIBIT 10.4 ex_198816.htm EX-10.4 50946
3 EXHIBIT 31.1 ex_196948.htm EX-31.1 14053
4 EXHIBIT 31.2 ex_196949.htm EX-31.2 14091
5 EXHIBIT 32.1 ex_196953.htm EX-32.1 4933
6 EXHIBIT 32.2 ex_196957.htm EX-32.2 5254
  Complete submission text file 0001437749-20-017410.txt   2666331

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT snbp-20200630.xml EX-101.INS 411630
8 XBRL TAXONOMY EXTENSION SCHEMA snbp-20200630.xsd EX-101.SCH 30125
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE snbp-20200630_cal.xml EX-101.CAL 24819
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snbp-20200630_def.xml EX-101.DEF 192148
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE snbp-20200630_lab.xml EX-101.LAB 179168
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snbp-20200630_pre.xml EX-101.PRE 210671
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Sun BioPharma, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55242 | Film No.: 201091088
SIC: 2834 Pharmaceutical Preparations